LetterSevere acute respiratory syndrome coronavirus 2 infection in those on mepolizumab therapy
Cited by (0)
Disclosures: Dr Howarth reports employment by GlaxoSmithKline. The remaining authors have no conflicts of interest to report.
Funding: The authors have no funding sources to report.
© 2021 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.